The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

The global US Biomarkers Market is expected to reach US$34.3 billion by 2029 from US$20.5 billion in 2024, at a CAGR of 10.8% ...

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...

The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.

Mycoplasma pneumoniae pneumonia (MPP) is a bacterial pathogen that causes pneumonia in school-aged children and adolescents.

Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

Rosemary Aoko has been buying antiretroviral (ARV) medication for two of her relatives. She found the free medication system too cumbersome, often plagued by stockouts, shortages of preferred drugs, ...

IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...

The global mycotoxin testing market is poised for substantial growth, with its valuation expected to rise from 𝐔𝐒𝐃 ...